ReShape Lifesciences (Formally known as EnteroMedics)

280 articles about ReShape Lifesciences (Formally known as EnteroMedics)

• EnteroMedics Inc. to Present at the Morgan Stanley Global Healthcare Unplugged Conference

  9/2/2008

• EnteroMedics Inc. to Present at the 28th Annual Canaccord Adams Global Growth Conference

  7/28/2008

• EnteroMedics Inc. Reports Second Quarter 2008 Financial Results

  7/25/2008

• EnteroMedics Inc. Receives ISO 13485:2003 Certification for the Maestro™ System

  6/27/2008

• EnteroMedics Inc. Receives ISO 13485:2003 Certification for the Maestro(TM) System

  6/27/2008

• EnteroMedics Inc.' Data from VBLOC-RF2 Feasibility Study and VBLOC-RC Study Presented Today at the American Society for Metabolic and Bariatric Surgery Meeting

  6/19/2008

• EnteroMedics Inc. to Host Conference Call after Presentation at the 25th Annual American Society for Metabolic and Bariatric Surgery Meeting

  6/12/2008

• EnteroMedics Inc. Reports First Quarter 2008 Financial Results

  4/24/2008

• EnteroMedics Inc. to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference

  4/22/2008

• EnteroMedics Inc. Announces Departure of Russell Felkey

  4/21/2008

• EnteroMedics Inc. to Present at the 28th Annual Cowen and Company Healthcare Conference

  3/12/2008

• EnteroMedics Inc. Announces Planned Expansion of EMPOWER Pivotal Study for Obesity to 300 Patients

  2/27/2008

• EnteroMedics Inc. Reports 2007 Year-End Financial Results

  2/21/2008

• EnteroMedics Inc. Sets Date and Time for 2007 Year-End Update Conference Call

  2/8/2008

• EnteroMedics Inc. Announces Nine-Month Clinical Results on Its VBLOC-RF2 Feasibility Study for Obesity Therapy

  1/9/2008

• EnteroMedics Inc.™ Announces Pivotal Clinical Study of its VBLOC™ Therapy for Obesity

  1/8/2008

• EnteroMedics Inc. Shares Rise in Debut

  11/16/2007

• EnteroMedics Inc. Announces Initial Public Offering

  11/15/2007

• EnteroMedics Inc. Files Registration Statement for Proposed Initial Public Offering

  5/25/2007

• EnteroMedics Inc. Closes $45.2 Million Series C Financing

  7/19/2006